| Year |
Citation |
Score |
| 2022 |
Sivakumaran D, Jenum S, Ritz C, Vaz M, Doherty TM, Grewal HMS. Improving Assignments for Therapeutic and Prophylactic Treatment Within TB Households. A Potential for Immuno-Diagnosis? Frontiers in Immunology. 13: 801616. PMID 35401549 DOI: 10.3389/fimmu.2022.801616 |
0.349 |
|
| 2020 |
Bekken GK, Ritz C, Selvam S, Jesuraj N, Hesseling AC, Doherty TM, Grewal HMS, Vaz M, Jenum S. Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations Bmc Infectious Diseases. 20: 1-11. PMID 32005136 DOI: 10.1186/S12879-020-4800-Y |
0.406 |
|
| 2019 |
Doherty TM, Di Pasquale A, Michel JP, Del Giudice G. Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review). Gerontology. 1-11. PMID 31770750 DOI: 10.1159/000503141 |
0.33 |
|
| 2019 |
Cohet C, van der Most R, Bauchau V, Bekkat-Berkani R, Doherty TM, Schuind A, Tavares Da Silva F, Rappuoli R, Garçon N, Innis BL. Safety of AS03-adjuvanted influenza vaccines: A review of the evidence. Vaccine. 37: 3006-3021. PMID 31031030 DOI: 10.1016/J.Vaccine.2019.04.048 |
0.329 |
|
| 2019 |
Vojtek I, Buchy P, Doherty TM, Hoet B. Would immunization be the same without cross-reactivity? Vaccine. 37: 539-549. PMID 30591255 DOI: 10.1016/J.Vaccine.2018.12.005 |
0.389 |
|
| 2018 |
de Gomensoro E, Del Giudice G, Doherty TM. Challenges in adult vaccination. Annals of Medicine. 50: 181-192. PMID 29338438 DOI: 10.1080/07853890.2017.1417632 |
0.365 |
|
| 2018 |
Hussein J, Zewdie M, Yamuah L, Bedru A, Abebe M, Dagnew AF, Chanyalew M, Yohannes AG, Ahmed J, Engers H, Doherty TM, Bang P, Kromann I, Hoff ST, Aseffa A. A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area. Trials. 19: 24. PMID 29321075 DOI: 10.1186/S13063-017-2354-0 |
0.422 |
|
| 2018 |
Vojtek I, Dieussaert I, Doherty TM, Franck V, Hanssens L, Miller J, Bekkat-Berkani R, Kandeil W, Prado-Cohrs D, Vyse A. Maternal immunization: Where are we now and how to move forward? Annals of Medicine. 1-36. PMID 29308916 DOI: 10.1080/07853890.2017.1421320 |
0.349 |
|
| 2016 |
Jenum S, Bakken R, Dhanasekaran S, Mukherjee A, Lodha R, Singh S, Singh V, Haks MC, Ottenhoff TH, Kabra SK, Doherty TM, Ritz C, Grewal HM. BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome. Scientific Reports. 6: 38841. PMID 27941850 DOI: 10.1038/Srep38841 |
0.359 |
|
| 2016 |
Zewdie M, Howe R, Hoff ST, Doherty TM, Getachew N, Tarekegne A, Tessema B, Yamuah L, Aseffa A, Abebe M. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls. Tuberculosis (Edinburgh, Scotland). 100: 61-8. PMID 27553411 DOI: 10.1016/J.Tube.2016.06.007 |
0.431 |
|
| 2016 |
Uppada DR, Selvam S, Jesuraj N, Lau EL, Doherty TM, Grewal HM, Vaz M, Lindtjørn B. Incidence of tuberculosis among school-going adolescents in South India. Bmc Public Health. 16: 641. PMID 27461229 DOI: 10.1186/S12889-016-3342-0 |
0.37 |
|
| 2016 |
Jenum S, Dhanasekaran S, Lodha R, Mukherjee A, Kumar Saini D, Singh S, Singh V, Medigeshi G, Haks MC, Ottenhoff TH, Doherty TM, Kabra SK, Ritz C, Grewal HM. Approaching a diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrum. Scientific Reports. 6: 18520. PMID 26725873 DOI: 10.1038/srep18520 |
0.308 |
|
| 2015 |
Rakotosamimanana N, Richard V, Raharimanga V, Gicquel B, Doherty TM, Zumla A, Rasolofo Razanamparany V. Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort study. The European Respiratory Journal. 46: 1095-103. PMID 26250497 DOI: 10.1183/13993003.00263-2015 |
0.408 |
|
| 2014 |
Dhanasekaran S, Jenum S, Stavrum R, Wiker HG, Kenneth J, Vaz M, Doherty TM, Grewal HM. Effect of non-tuberculous Mycobacteria on host biomarkers potentially relevant for tuberculosis management. Plos Neglected Tropical Diseases. 8: e3243. PMID 25329719 DOI: 10.1371/Journal.Pntd.0003243 |
0.447 |
|
| 2014 |
Jenum S, Grewal HM, Hokey DA, Kenneth J, Vaz M, Doherty TM, Jahnsen FL. The frequencies of IFNγ+IL2+TNFα+ PPD-specific CD4+CD45RO+ T-cells correlate with the magnitude of the QuantiFERON® gold in-tube response in a prospective study of healthy indian adolescents. Plos One. 9: e101224. PMID 24992314 DOI: 10.1371/journal.pone.0101224 |
0.346 |
|
| 2014 |
Dhanasekaran S, Jenum S, Stavrum R, Ritz C, Kenneth J, Vaz M, Doherty TM, Grewal HM. Concordant or discordant results by the tuberculin skin test and the quantiFERON-TB test in children reflect immune biomarker profiles. Genes and Immunity. 15: 265-74. PMID 24739497 DOI: 10.1038/gene.2014.13 |
0.319 |
|
| 2013 |
Hur YG, Gorak-Stolinska P, Ben-Smith A, Lalor MK, Chaguluka S, Dacombe R, Doherty TM, Ottenhoff TH, Dockrell HM, Crampin AC. Combination of cytokine responses indicative of latent TB and active TB in Malawian adults. Plos One. 8: e79742. PMID 24260295 DOI: 10.1371/Journal.Pone.0079742 |
0.454 |
|
| 2013 |
Dhanasekaran S, Jenum S, Stavrum R, Ritz C, Faurholt-Jepsen D, Kenneth J, Vaz M, Grewal HM, Doherty TM. Identification of biomarkers for Mycobacterium tuberculosis infection and disease in BCG-vaccinated young children in Southern India. Genes and Immunity. 14: 356-64. PMID 23676757 DOI: 10.1038/gene.2013.26 |
0.325 |
|
| 2013 |
Rakotosamimanana N, Doherty TM, Andriamihantasoa LH, Richard V, Gicquel B, Soares JL, Zumla A, Razanamparany VR. Expression of TNF-alpha-dependent apoptosis-related genes in the peripheral blood of Malagasy subjects with tuberculosis. Plos One. 8: e61154. PMID 23593415 DOI: 10.1371/Journal.Pone.0061154 |
0.443 |
|
| 2012 |
Corbière V, Pottier G, Bonkain F, Schepers K, Verscheure V, Lecher S, Doherty TM, Locht C, Mascart F. Risk stratification of latent tuberculosis defined by combined interferon gamma release assays. Plos One. 7: e43285. PMID 22912846 DOI: 10.1371/Journal.Pone.0043285 |
0.454 |
|
| 2012 |
Dagnew AF, Hussein J, Abebe M, Zewdie M, Mihret A, Bedru A, Chanyalew M, Yamuah L, Medhin G, Bang P, Doherty TM, Hailu A, Aseffa A. Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth. Bmc Research Notes. 5: 415. PMID 22870897 DOI: 10.1186/1756-0500-5-415 |
0.441 |
|
| 2012 |
Doherty TM. Immunotherapy for TB. Immunotherapy. 4: 629-47. PMID 22788130 DOI: 10.2217/Imt.12.52 |
0.468 |
|
| 2012 |
Chegou NN, Black GF, Loxton AG, Stanley K, Essone PN, Klein MR, Parida SK, Kaufmann SH, Doherty TM, Friggen AH, Franken KL, Ottenhoff TH, Walzl G. Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. Bmc Infectious Diseases. 12: 10. PMID 22260319 DOI: 10.1186/1471-2334-12-10 |
0.459 |
|
| 2011 |
Stavrum R, Stavrum AK, Valvatne H, Riley LW, Ulvestad E, Jonassen I, Assmus J, Doherty TM, Grewal HM. Modulation of transcriptional and inflammatory responses in murine macrophages by the Mycobacterium tuberculosis mammalian cell entry (Mce) 1 complex. Plos One. 6: e26295. PMID 22039457 DOI: 10.1371/Journal.Pone.0026295 |
0.39 |
|
| 2011 |
van Dissel JT, Soonawala D, Joosten SA, Prins C, Arend SM, Bang P, Tingskov PN, Lingnau K, Nouta J, Hoff ST, Rosenkrands I, Kromann I, Ottenhoff TH, Doherty TM, Andersen P. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection. Vaccine. 29: 2100-9. PMID 21256189 DOI: 10.1016/J.Vaccine.2010.12.135 |
0.475 |
|
| 2011 |
Abebe M, Kim L, Rook G, Aseffa A, Wassie L, Zewdie M, Zumla A, Engers H, Andersen P, Doherty TM. Modulation of cell death by M. tuberculosis as a strategy for pathogen survival. Clinical & Developmental Immunology. 2011: 678570. PMID 21253484 DOI: 10.1155/2011/678570 |
0.423 |
|
| 2010 |
Ottenhoff TH, Doherty TM, van Dissel JT, Bang P, Lingnau K, Kromann I, Andersen P. First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses. Human Vaccines. 6: 1007-15. PMID 21178394 DOI: 10.4161/Hv.6.12.13143 |
0.466 |
|
| 2010 |
Gennaro ML, Doherty TM. Immunodiagnosis of Tuberculosis: New Questions, New Tools Virginia, VA, USA. 21-23 September 2008. Abstracts. Bmc Proceedings. 4: I1. PMID 21172041 DOI: 10.1186/1753-6561-4-S3-I1 |
0.422 |
|
| 2010 |
Place S, Verscheure V, de San N, Hougardy JM, Schepers K, Dirix V, Dediste A, Michel O, Drowart A, Allard SD, Doherty TM, Lecher S, Locht C, Mascart F. Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans. American Journal of Respiratory and Critical Care Medicine. 182: 848-54. PMID 20508213 DOI: 10.1164/Rccm.201001-0083Oc |
0.476 |
|
| 2010 |
Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet (London, England). 375: 1920-37. PMID 20488517 DOI: 10.1016/S0140-6736(10)60359-5 |
0.42 |
|
| 2010 |
Rakotosamimanana N, Raharimanga V, Andriamandimby SF, Soares JL, Doherty TM, Ratsitorahina M, Ramarokoto H, Zumla A, Huggett J, Rook G, Richard V, Gicquel B, Rasolofo-Razanamparany V. Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar. Clinical and Vaccine Immunology : Cvi. 17: 1094-103. PMID 20463103 DOI: 10.1128/Cvi.00049-10 |
0.428 |
|
| 2010 |
van Dissel JT, Arend SM, Prins C, Bang P, Tingskov PN, Lingnau K, Nouta J, Klein MR, Rosenkrands I, Ottenhoff TH, Kromann I, Doherty TM, Andersen P. Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers. Vaccine. 28: 3571-81. PMID 20226890 DOI: 10.1016/J.Vaccine.2010.02.094 |
0.477 |
|
| 2010 |
Gallant CJ, Cobat A, Simkin L, Black GF, Stanley K, Hughes J, Doherty TM, Hanekom WA, Eley B, Beyers N, Jaïs JP, van Helden P, Abel L, Alcaïs A, Hoal EG, et al. Tuberculin skin test and in vitro assays provide complementary measures of antimycobacterial immunity in children and adolescents. Chest. 137: 1071-7. PMID 20040612 DOI: 10.1378/Chest.09-1852 |
0.38 |
|
| 2010 |
Kang JSL, Cherian A, Gan SH, Lee TH, Lee KC, Chee CBE, Doherty TM, Wang YT, Seah GT. Strong purified protein derivative responses are associated with poor mycobacterium inhibition in latent TB European Respiratory Journal. 36: 348-354. PMID 19996195 DOI: 10.1183/09031936.00063209 |
0.354 |
|
| 2010 |
Cobat A, Gallant CJ, Simkin L, Black GF, Stanley K, Hughes J, Doherty TM, Hanekom WA, Eley B, Beyers N, Jaïs JP, van Helden P, Abel L, Hoal EG, Alcaïs A, et al. High heritability of antimycobacterial immunity in an area of hyperendemicity for tuberculosis disease. The Journal of Infectious Diseases. 201: 15-9. PMID 19938975 DOI: 10.1086/648611 |
0.438 |
|
| 2010 |
Abebe M, Doherty TM, Wassie L, Aseffa A, Bobosha K, Demissie A, Zewdie M, Engers H, Andersen P, Kim L, Huggett J, Rook G, Yamuah LK, Zumla A. Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical status. European Journal of Immunology. 40: 291-301. PMID 19877018 DOI: 10.1002/Eji.200939856 |
0.388 |
|
| 2010 |
Wallis RS, Doherty TM, Zumla A. Biomarkers for tuberculosis disease activity, cure, and relapse - Authors' reply The Lancet Infectious Diseases. 10: 70-71. DOI: 10.1016/S1473-3099(10)70002-5 |
0.349 |
|
| 2009 |
Doherty TM, Wallis RS, Zumla A. Biomarkers of disease activity, cure, and relapse in tuberculosis. Clinics in Chest Medicine. 30: 783-96, x. PMID 19925967 DOI: 10.1016/J.Ccm.2009.08.008 |
0.401 |
|
| 2009 |
Cobat A, Gallant CJ, Simkin L, Black GF, Stanley K, Hughes J, Doherty TM, Hanekom WA, Eley B, Jaïs JP, Boland-Auge A, van Helden P, Casanova JL, Abel L, Hoal EG, et al. Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis. The Journal of Experimental Medicine. 206: 2583-91. PMID 19901083 DOI: 10.1084/Jem.20090892 |
0.397 |
|
| 2009 |
Søborg C, Mølbak K, Doherty TM, Ulleryd P, Brooks T, Coenen C, van der Zeijst B. Vaccines in a hurry. Vaccine. 27: 3295-8. PMID 19460599 DOI: 10.1016/J.Vaccine.2009.02.030 |
0.379 |
|
| 2009 |
Dietrich J, Doherty TM. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 117: 440-57. PMID 19400867 DOI: 10.1111/J.1600-0463.2009.02458.X |
0.488 |
|
| 2009 |
Wallis RS, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S, Zumla A. Biomarkers for tuberculosis disease activity, cure, and relapse. The Lancet. Infectious Diseases. 9: 162-72. PMID 19246020 DOI: 10.1016/S1473-3099(09)70042-8 |
0.388 |
|
| 2008 |
Hanekom WA, Dockrell HM, Ottenhoff TH, Doherty TM, Fletcher H, McShane H, Weichold FF, Hoft DF, Parida SK, Fruth UJ. Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. Plos Medicine. 5: e145. PMID 18597551 DOI: 10.1371/Journal.Pmed.0050145 |
0.419 |
|
| 2008 |
Boraschi D, Abebe Alemayehu M, Aseffa A, Chiodi F, Chisi J, Del Prete G, Doherty TM, Elhassan I, Engers H, Gyan B, Harandi AM, Kariuki T, Kironde F, Kouriba B, Langhorne J, et al. Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities. Plos Neglected Tropical Diseases. 2: e255. PMID 18575596 DOI: 10.1371/Journal.Pntd.0000255 |
0.39 |
|
| 2008 |
Wassie L, Demissie A, Aseffa A, Abebe M, Yamuah L, Tilahun H, Petros B, Rook G, Zumla A, Andersen P, Doherty TM. Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time. Plos One. 3: e1522. PMID 18231607 DOI: 10.1371/Journal.Pone.0001522 |
0.387 |
|
| 2007 |
Doherty TM, Dietrich J, Billeskov R. Tuberculosis subunit vaccines: from basic science to clinical testing. Expert Opinion On Biological Therapy. 7: 1539-49. PMID 17916046 DOI: 10.1517/14712598.7.10.1539 |
0.439 |
|
| 2007 |
Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends in Molecular Medicine. 13: 175-82. PMID 17418641 DOI: 10.1016/J.Molmed.2007.03.004 |
0.428 |
|
| 2007 |
Dietrich J, Billeskov R, Doherty TM, Andersen P. Synergistic effect of bacillus calmette guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection. Journal of Immunology (Baltimore, Md. : 1950). 178: 3721-30. PMID 17339470 DOI: 10.4049/Jimmunol.178.6.3721 |
0.403 |
|
| 2006 |
Bennekov T, Dietrich J, Rosenkrands I, Stryhn A, Doherty TM, Andersen P. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis. European Journal of Immunology. 36: 3346-55. PMID 17109467 DOI: 10.1002/Eji.200636128 |
0.455 |
|
| 2006 |
Dietrich J, Andersen C, Rappuoli R, Doherty TM, Jensen CG, Andersen P. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. Journal of Immunology (Baltimore, Md. : 1950). 177: 6353-60. PMID 17056566 DOI: 10.4049/Jimmunol.177.9.6353 |
0.485 |
|
| 2006 |
Demissie A, Wassie L, Abebe M, Aseffa A, Rook G, Zumla A, Andersen P, Doherty TM. The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon. Infection and Immunity. 74: 2817-22. PMID 16622219 DOI: 10.1128/Iai.74.5.2817-2822.2006 |
0.445 |
|
| 2006 |
Doherty TM, Rook G. Progress and hindrances in tuberculosis vaccine development. Lancet (London, England). 367: 947-9. PMID 16546547 DOI: 10.1016/S0140-6736(06)68389-X |
0.453 |
|
| 2006 |
Demissie A, Leyten EM, Abebe M, Wassie L, Aseffa A, Abate G, Fletcher H, Owiafe P, Hill PC, Brookes R, Rook G, Zumla A, Arend SM, Klein M, Ottenhoff TH, ... ... Doherty TM, et al. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clinical and Vaccine Immunology : Cvi. 13: 179-86. PMID 16467323 DOI: 10.1128/Cvi.13.2.179-186.2006 |
0.487 |
|
| 2005 |
Andersen P, Doherty TM. Learning from BCG: Designing a better tuberculosis vaccine. Discovery Medicine. 5: 383-7. PMID 20704877 |
0.354 |
|
| 2005 |
Doherty TM, Andersen P. Vaccines for tuberculosis: novel concepts and recent progress. Clinical Microbiology Reviews. 18: 687-702. PMID 16223953 DOI: 10.1128/Cmr.18.4.687-702.2005 |
0.453 |
|
| 2005 |
Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nature Reviews. Microbiology. 3: 656-62. PMID 16012514 DOI: 10.1038/Nrmicro1211 |
0.464 |
|
| 2005 |
Dietrich J, Aagaard C, Leah R, Olsen AW, Stryhn A, Doherty TM, Andersen P. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. Journal of Immunology (Baltimore, Md. : 1950). 174: 6332-9. PMID 15879133 DOI: 10.4049/Jimmunol.174.10.6332 |
0.453 |
|
| 2005 |
Andersen P, Doherty TM. TB subunit vaccines--putting the pieces together. Microbes and Infection. 7: 911-21. PMID 15878836 DOI: 10.1016/J.Micinf.2005.03.013 |
0.429 |
|
| 2005 |
Doherty TM, Demissie A, Menzies D, Andersen P, Rook G, Zumla A. Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR Journal of Immunological Methods. 298: 129-141. PMID 15847803 DOI: 10.1016/J.Jim.2005.01.013 |
0.385 |
|
| 2005 |
Langermans JAM, Doherty TM, Vervenne RAW, Laan Tvd, Lyashchenko K, Greenwald R, Agger EM, Aagaard C, Weiler H, Soolingen Dv, Dalemans W, Thomas AW, Andersen P. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine. 23: 2740-2750. PMID 15780721 DOI: 10.1016/J.Vaccine.2004.11.051 |
0.459 |
|
| 2005 |
Doherty TM. Real world TB vaccines: clinical trials in TB-endemic regions. Vaccine. 23: 2109-14. PMID 15755580 DOI: 10.1016/j.vaccine.2005.01.060 |
0.336 |
|
| 2005 |
Williams A, Hatch GJ, Clark SO, Gooch KE, Hatch KA, Hall GA, Huygen K, Ottenhoff TH, Franken KL, Andersen P, Doherty TM, Kaufmann SH, Grode L, Seiler P, Martin C, et al. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis (Edinburgh, Scotland). 85: 29-38. PMID 15687025 DOI: 10.1016/J.Tube.2004.09.009 |
0.417 |
|
| 2005 |
Weldingh K, Rosenkrands I, Okkels LM, Doherty TM, Andersen P. Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens. Journal of Clinical Microbiology. 43: 57-65. PMID 15634951 DOI: 10.1128/JCM.43.1.57-65.2005 |
0.31 |
|
| 2004 |
Doherty TM, Olsen AW, Weischenfeldt J, Huygen K, D'Souza S, Kondratieva TK, Yeremeev VV, Apt AS, Raupach B, Grode L, Kaufmann SHE, Andersen P. Comparative Analysis of Different Vaccine Constructs Expressing Defined Antigens from Mycobacterium tuberculosis The Journal of Infectious Diseases. 190: 2146-2153. PMID 15551213 DOI: 10.1086/425931 |
0.401 |
|
| 2004 |
Fletcher HA, Owiafe P, Jeffries D, Hill P, Rook GAW, Zumla A, Doherty TM, Brookes RH. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology. 112: 669-673. PMID 15270739 DOI: 10.1111/J.1365-2567.2004.01922.X |
0.369 |
|
| 2004 |
Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, Zumla A, Weldingh K, Brock I, Andersen P, Doherty TM. Healthy Individuals That Control a Latent Infection with Mycobacterium tuberculosis Express High Levels of Th1 Cytokines and the IL-4 Antagonist IL-4δ2 Journal of Immunology. 172: 6938-6943. PMID 15153513 DOI: 10.4049/Jimmunol.172.11.6938 |
0.475 |
|
| 2004 |
Holten-Andersen L, Doherty TM, Korsholm KS, Andersen P. Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines. Infection and Immunity. 72: 1608-17. PMID 14977968 DOI: 10.1128/IAI.72.3.1608-1617.2004 |
0.38 |
|
| 2003 |
Rolinck-Werninghaus C, Magdorf K, Stark K, Lyashchenko K, Gennaro ML, Colangeli R, Doherty TM, Andersen P, Plum G, Herz U, Renz H, Wahn U. The potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection European Journal of Pediatrics. 162: 534-536. PMID 12715165 DOI: 10.1007/S00431-003-1199-6 |
0.457 |
|
| 2003 |
Okkels LM, Doherty TM, Andersen P. Selecting the components for a safe and efficient tuberculosis subunit vaccine--recent progress and post-genomic insights. Current Pharmaceutical Biotechnology. 4: 69-83. PMID 12570683 DOI: 10.2174/1389201033377931 |
0.403 |
|
| 2002 |
Hale-Donze H, Greenwell-Wild T, Mizel D, Doherty TM, Chatterjee D, Orenstein JM, Wahl SM. Mycobacterium avium complex promotes recruitment of monocyte hosts for HIV-1 and bacteria. Journal of Immunology (Baltimore, Md. : 1950). 169: 3854-62. PMID 12244182 DOI: 10.4049/Jimmunol.169.7.3854 |
0.319 |
|
| 2002 |
Doherty TM, Olsen AW, Pinxteren Lv, Andersen P. Oral Vaccination with Subunit Vaccines Protects Animals against Aerosol Infection with Mycobacterium tuberculosis Infection and Immunity. 70: 3111-3121. PMID 12011005 DOI: 10.1128/Iai.70.6.3111-3121.2002 |
0.47 |
|
| 2002 |
Doherty TM, Andersen P. Tuberculosis vaccine development. Current Opinion in Pulmonary Medicine. 8: 183-187. PMID 11981306 DOI: 10.1097/00063198-200205000-00006 |
0.442 |
|
| 2002 |
Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, Eguale T, Ravn P, Andersen P. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. Journal of Clinical Microbiology. 40: 704-706. PMID 11826002 DOI: 10.1128/Jcm.40.2.704-706.2002 |
0.452 |
|
| 2001 |
Wu-Hsieh BA, Chen C, Chang J, Lai S, Wu CHH, Cheng W, Andersen P, Doherty TM. Long-Lived Immune Response to Early Secretory Antigenic Target 6 in Individuals Who Had Recovered from Tuberculosis Clinical Infectious Diseases. 33: 1336-1340. PMID 11565073 DOI: 10.1086/323044 |
0.458 |
|
| 2000 |
Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet (London, England). 356: 1099-104. PMID 11009160 DOI: 10.1016/s0140-6736(00)02742-2 |
0.361 |
|
| 2000 |
Doherty TM, Andersen P. Tuberculosis vaccines: developmental work and the future. Current Opinion in Pulmonary Medicine. 6: 203-8. PMID 10782704 DOI: 10.1097/00063198-200005000-00007 |
0.316 |
|
| 1999 |
Demissie A, Ravn P, Olobo J, Doherty TM, Eguale T, Geletu M, Hailu W, Andersen P, Britton S. T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts. Infection and Immunity. 67: 5967-5971. PMID 10531255 DOI: 10.1128/Iai.67.11.5967-5971.1999 |
0.464 |
|
| 1999 |
Doherty TM, Coffman RL. Ability of macrophage subsets to transfer resistance to murine leishmaniasis is dependent on IL-12 production. European Journal of Immunology. 29: 522-9. PMID 10064067 DOI: 10.1002/(Sici)1521-4141(199902)29:02<522::Aid-Immu522>3.0.Co;2-U |
0.587 |
|
| 1999 |
Segal BH, Doherty TM, Wynn TA, Cheever AW, Sher A, Holland SM. The p47phox−/− Mouse Model of Chronic Granulomatous Disease Has Normal Granuloma Formation and Cytokine Responses to Mycobacterium avium and Schistosoma mansoni Eggs Infection and Immunity. 67: 1659-1665. DOI: 10.1128/Iai.67.4.1659-1665.1999 |
0.345 |
|
| 1997 |
Giese NA, Gabriele L, Doherty TM, Klinman DM, Tadesse-Heath L, Contursi C, Epstein SL, Morse HC. Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression Journal of Experimental Medicine. 186: 1535-1546. PMID 9348311 DOI: 10.1084/Jem.186.9.1535 |
0.388 |
|
| 1997 |
Doherty TM, Giese N, Morse HC, Coffman RL. Modulation of murine AIDS-related pathology by concurrent antibody treatment and coinfection with Leishmania major. Journal of Virology. 71: 3702-9. PMID 9094644 DOI: 10.1128/JVI.71.5.3702-3709.1997 |
0.526 |
|
| 1996 |
Doherty TM, Coffman RL. Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Experimental Parasitology. 84: 124-35. PMID 8932762 DOI: 10.1006/expr.1996.0098 |
0.529 |
|
| 1996 |
Morawetz RA, Gabriele L, Rizzo LV, Noben-Trauth N, Kühn R, Rajewsky K, Müller W, Doherty TM, Finkelman F, Coffman RL, Morse HC. Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse. The Journal of Experimental Medicine. 184: 1651-61. PMID 8920855 DOI: 10.1084/Jem.184.5.1651 |
0.473 |
|
| 1995 |
Doherty TM, Morse HC, Coffman RL. Modulation of specific T cell responses by concurrent infection with Leishmania major and LP-BM5 murine leukemia viruses. International Immunology. 7: 131-8. PMID 7718509 DOI: 10.1093/intimm/7.1.131 |
0.54 |
|
| 1995 |
Doherty TM. T-cell regulation of macrophage function. Current Opinion in Immunology. 7: 400-404. PMID 7546407 DOI: 10.1016/0952-7915(95)80117-0 |
0.316 |
|
| 1993 |
Doherty TM, Coffman RL. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. Journal of Immunology (Baltimore, Md. : 1950). 150: 5476-83. PMID 8515072 |
0.532 |
|
| 1993 |
Doherty TM, Kastelein R, Menon S, Andrade S, Coffman RL. Modulation of murine macrophage function by IL-13. Journal of Immunology (Baltimore, Md. : 1950). 151: 7151-60. PMID 7903102 |
0.494 |
|
| Show low-probability matches. |